| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +0.00% | +2.51% | -1.28% | +3.80% | +3.80% | — |
| 14d | 1 | +100.00% | -10.71% | -3.46% | -7.25% | -7.25% | — |
| 30d | 1 | +0.00% | +17.79% | -4.28% | +22.07% | +22.07% | — |
| 60d | 1 | +100.00% | -32.94% | +4.80% | -37.74% | -37.74% | — |
| 90d | 1 | +100.00% | -15.08% | — | — | — | — |
| 180d | 1(1 pending) | — | — | — | — | — | — |
| 1y | 1(1 pending) | — | — | — | — | — | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ERAS ERASCA, INC. | SALE10b5-1 10b5-1 plan | 20,000 | $15.04 | $300.8K | 0 | Mar 4, 2026 | Mar 6, 2026 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASE Chief Medical Officer | 20,000 | $1.70 | $34.0K | 20,000 | Mar 4, 2026 | Mar 6, 2026 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASEGRANT Stock grant | 625,000 | — | — | 625,000 | Jan 29, 2026 | Jan 30, 2026 ↗ | View → |
| ERAS ERASCA, INC. | SALE Chief Medical Officer | 20,000 | — | — | 515,800 | Mar 4, 2025 | Mar 6, 2026 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASEGRANT Stock grant | 780,000 | — | — | 780,000 | Feb 3, 2025 | Feb 5, 2025 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASEGRANT Stock grant | 137,142 | — | — | 137,142 | Jun 20, 2024 | Jun 21, 2024 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASEGRANT Stock grant | 535,800 | — | — | 535,800 | Feb 5, 2024 | Feb 7, 2024 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASEGRANT Stock grant | 375,000 | — | — | 375,000 | Apr 10, 2023 | Apr 13, 2023 ↗ | View → |